Sttudents' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
Nutr Neurosci. 2022 Dec;25(12):2507-2516. doi: 10.1080/1028415X.2021.1980844. Epub 2021 Oct 11.
Although glycemic index (GI) and load (GL) have been linked with several health outcomes, no information is available linking dietary GI and GL with glioma. This study aimed to investigate the relationship between dietary GI and GL and odds of glioma.
This hospital-based case-control study was conducted between November 2009 and September 2011 in the hospital affiliated to Shahid Beheshti University of Medical Sciences. We recruited 128 newly diagnosed cases of glioma and 256 age- and sex-matched controls. All cases were pathologically diagnosed with glioma patients, with no history of any type of other pathologically confirmed cancers and chemotherapy or radiotherapy (due to cancers). Dietary GI and GL were measured by using a validated, self-administered, dish-based, semi-quantitative food-frequency questionnaire.
A significant positive association was found between dietary GI and glioma (OR: 3.01; 95% CI: 1.75-5.17, < 0.001); such that after considering for potential confounders, participants in the highest tertile of dietary GI had 3.51 times greater risk of glioma than those in the lowest tertile (OR: 3.51; 95% CI: 1.69-7.28, = 0.001). Furthermore, we observed a significant positive association between dietary and glioma (OR: 3.74; 95% CI: 1.97-6.11, < 0.001). This association remained significant even after further controlling for potential confounders (OR: 2.42; 95% CI: 1.02-5.69, = 0.04).
We observed a significant positive association between dietary GI and GL and risk of glioma in adults. However, prospective cohort studies are required to confirm this association.
尽管血糖指数(GI)和负荷(GL)与多种健康结果相关,但尚无信息表明饮食 GI 和 GL 与神经胶质瘤有关。本研究旨在调查饮食 GI 和 GL 与神经胶质瘤发病风险之间的关系。
这是一项 2009 年 11 月至 2011 年 9 月在沙希德贝赫什提大学医学科学附属医院进行的基于医院的病例对照研究。我们招募了 128 例新诊断的神经胶质瘤病例和 256 名年龄和性别匹配的对照。所有病例均经病理诊断为神经胶质瘤患者,且无任何其他经病理证实的癌症和化疗或放疗(因癌症)的病史。通过使用经过验证的、自我管理的、基于餐盘的半定量食物频率问卷来测量饮食 GI 和 GL。
饮食 GI 与神经胶质瘤呈显著正相关(OR:3.01;95%CI:1.75-5.17,<0.001);在考虑到潜在混杂因素后,饮食 GI 最高 tertile 组的参与者患神经胶质瘤的风险比最低 tertile 组高 3.51 倍(OR:3.51;95%CI:1.69-7.28,=0.001)。此外,我们观察到饮食与神经胶质瘤之间存在显著正相关(OR:3.74;95%CI:1.97-6.11,<0.001)。即使进一步控制了潜在混杂因素(OR:2.42;95%CI:1.02-5.69,=0.04),这种关联仍然显著。
我们观察到饮食 GI 和 GL 与成年人神经胶质瘤发病风险之间存在显著正相关。然而,需要进行前瞻性队列研究来证实这种关联。